These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1588139)

  • 1. Cell surface changes in Haemophilus influenzae type b associated with a phenotypic increase in resistance to bactericidal antibody.
    Loeb MR; Kuratana M; Anderson P
    J Infect Dis; 1992 Jun; 165 Suppl 1():S110-1. PubMed ID: 1588139
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple mechanisms in serum factor-induced resistance of Haemophilus influenzae type b to antibody.
    Kuratana M; Hansen EJ; Anderson P
    Infect Immun; 1990 Apr; 58(4):914-9. PubMed ID: 2318534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low milk IgA antibody to Haemophilus influenzae colonising nasopharynx of infants.
    von Rosen IA; Aniansson G; Svanborg Eden C; Lagergard T
    Lancet; 1990 Mar; 335(8688):548. PubMed ID: 1968563
    [No Abstract]   [Full Text] [Related]  

  • 4. Nasopharyngeal colonization by nontypeable Hemophilus influenzae in children: the effect of serum bactericidal antibody.
    Bernstein JM; Faden HS; Ogra PL
    Otolaryngol Head Neck Surg; 1991 Sep; 105(3):406-10. PubMed ID: 1945426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity.
    van Schilfgaarde M; Eijk P; Regelink A; van Ulsen P; Everts V; Dankert J; van Alphen L
    Microb Pathog; 1999 May; 26(5):249-62. PubMed ID: 10222210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum factor-dependent resistance of Haemophilus influenzae type b to antibody to lipopolysaccharide.
    Inzana TJ; Anderson P
    J Infect Dis; 1985 May; 151(5):869-77. PubMed ID: 2580914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic antigens of Haemophilus influenzae as vaccine components.
    Murphy TF; Campagnari AA; Nelson MB; Apicella MA
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S66-8. PubMed ID: 2648296
    [No Abstract]   [Full Text] [Related]  

  • 8. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against Haemophilus influenzae lipopolysaccharides: clone MAHI 4 binding to a pentasaccharide containing terminal beta-Gal residues and clone MAHI 10 recognizing terminal phosphorylated saccharide residues.
    Borrelli S; Jansson PE; Lindberg AA
    Microb Pathog; 1996 Nov; 21(5):307-18. PubMed ID: 8938639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
    Hirano T; Hou Y; Jiao X; Gu XX
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemically defined medium induces resistance to lipopolysaccharide antibody in Haemophilus influenzae type b.
    Inzana TJ
    Microb Pathog; 1986 Oct; 1(5):483-9. PubMed ID: 3509885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody responses to nonencapsulated Haemophilus influenzae isolated from the nasopharynx of children with pneumonia.
    Claesson BA; Lagergård T; Trollfors B
    J Infect Dis; 1992 Jun; 165 Suppl 1():S205-6. PubMed ID: 1588168
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens.
    Anderson P; Flesher A; Shaw S; Harding AL; Smith DH
    J Clin Invest; 1980 Apr; 65(4):885-91. PubMed ID: 6153662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary clearance of nontypable Haemophilus influenzae.
    Hansen EJ; Toews GB
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S69-72. PubMed ID: 2648297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fetal and neonatal transmission of type-b anti-haemophilus influenzae antibodies protecting the newborn rat].
    Robert A; Jouin H; Fournier JM
    Pathol Biol (Paris); 1983 Feb; 31(2):138-40. PubMed ID: 6341943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane proteins and lipopolysaccharides of nontypeable Haemophilus influenzae.
    Barenkamp SJ
    J Infect Dis; 1992 Jun; 165 Suppl 1():S181-4. PubMed ID: 1588159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of pilus vaccines for Haemophilus influenzae diseases.
    Brinton CC; Carter MJ; Derber DB; Kar S; Kramarik JA; To AC; To SC; Wood SW
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S54-61. PubMed ID: 2564658
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice.
    Cutter D; Mason KW; Howell AP; Fink DL; Green BA; St Geme JW
    J Infect Dis; 2002 Oct; 186(8):1115-21. PubMed ID: 12355362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the surface of Haemophilus influenzae.
    Gotoff SP
    J Infect Dis; 1981 May; 143(5):747-8. PubMed ID: 6972423
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.